Provided by Tiger Trade Technology Pte. Ltd.

Yesterday's Top Gainers

802.92
+1.300.16%
Number of Gainers:26
Number of Losers:22
Number of Flat:5
PE:- -
High:805.30
Open:800.55
Low:796.99
Close:801.61
Volume:88.62M
Turnover:1.25B
Market Cap:136.79B
Float Cap:83.44B

Loading ...

H World Group (HTHT) Stock Still Looks Like A Bargain After A 43% Gain

Simply Wall St.
·
Aug 25

Centrus Hosts Ohio Gov. DeWine, JobsOhio at Piketon Uranium Enrichment Facility

Reuters
·
Aug 25

Bridgford Foods FY26 Q3 Net Loss Widens to $7.78 Million; Net Sales Drop 9.5% to $47.02 Million

Reuters
·
Aug 25

MEC Forecasts $50 Million-$60 Million in 2026 Datacenter, Critical Power Cross-Selling Revenue

Reuters
·
Aug 25

Weatherford, NCS Multistage Set Aug. 31 Election Deadline Ahead of Anticipated Sept. 1 Merger Close

Reuters
·
Aug 25

Weatherford International - Co and NCS Multistage Set Aug 31, 2026 Election Deadline for Merger Consideration

THOMSON REUTERS
·
Aug 25

Analysts’ Top Industrial Goods Picks: Napco Security Technologies (NSSC), QXO Inc (QXO)

TIPRANKS
·
Aug 25

Top Midday Decliners

MT Newswires Live
·
Aug 25

Alert Incorrectly Tagged to RPC Inc Withdrawn

Reuters
·
Aug 25

RPC Acquires Peracidin® Product Line

THOMSON REUTERS
·
Aug 24

Why Is NAPCO Security Stock Soaring Monday?

Benzinga Earnings
·
Aug 24

Asian Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live
·
Aug 24

Enerya Enerji and TGS Dis Ticaret Declare Cash Dividends Effective August 25, 2026

TIPRANKS
·
Aug 24

Morning Movers: Regenxbio sinks following clinical hold on RGX-121

TIPRANKS
·
Aug 24

Humacyte Plans FDA Filing for Acellular Tissue Engineered Vessel in Dialysis Access

MT Newswires Live
·
Aug 24

GOLDWAY EDU Completes Share Placement, Raising Approximately HK$4.4 Million Net

Stock News
·
Aug 24

Regenxbio Stock Sinks 22% Following Surprise Finding in Gene Therapy Trial

Dow Jones
·
Aug 24

Humacyte Says Phase 3 V012 Trial Shows ATEV Extends Catheter-Free Dialysis Time in Women

Reuters
·
Aug 24

Humacyte - Seeks to Add Dialysis Access as Second Approved Indication for Atev

THOMSON REUTERS
·
Aug 24

Humacyte - Supplemental Bla to be Supported by Three Phase 3 Studies of Atev

THOMSON REUTERS
·
Aug 24